Transfusion practice in the ICU: When will we apply the evidence?

Chest

Volumn 127, Issue 3, 2005, Pages 702-705

  Shorr, Andrew F ^a,b   Jackson, William L ^a,b  

^a Walter Reed Army Medical Center ^*

^b WALTER REED ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANEMIA; BLOOD TRANSFUSION; CLINICAL PRACTICE; EDITORIAL; EVIDENCE BASED MEDICINE; HUMAN; INTENSIVE CARE; INTENSIVE CARE UNIT; PRIORITY JOURNAL; CRITICAL ILLNESS; NOTE;

HEMOGLOBIN;

ANEMIA; BLOOD TRANSFUSION; CRITICAL ILLNESS; EVIDENCE-BASED MEDICINE; HEMOGLOBINS; HUMANS; INTENSIVE CARE UNITS;

EID: 15844385323     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.127.3.702     Document Type: Article

References (22)

1. Vincent JL, Baron JF, Reinhart K, et al. Anemia and blood transfusion in critically ill patients. JAMA 2002; 288:1499-1507
2. Corwin HL, Gettinger A, Pearl RG, et al. The CRIT Study: anemia and blood transfusion in the critically ill; current clinical practice in the United States. Crit Care Med 2004; 32:39-52
3. Corwin HL, Parsonnet KC, Gettinger A. RBC transfusion in the ICU. Is there a reason? Chest 1995; 108:767-771
4. Rogiers P, Zhang H, Leeman M, et al. Erythropoietin response is blunted in critically ill patients. Intensive Care Med 1997; 23:159-162
5. Fink MP. Pathophysiology of intensive care unit-acquired anemia. Crit Care 2004; 8(suppl):S9-S10
6. Skobin V, Jelkmann W, Morschakova E, et al. Tumor necrosis factor-alpha and TNF beta inhibit clonogenicity of mobilized human hematopoietic progenitors. J Interferon Cytokine Res 2000; 20:507-510
7. Corwin HL. Anemia and blood transfusion in the critically ill patient: role of erythropoietin. Crit Care. 2004; 8(suppl):S42-S44
8. American Society of Anesthesiologists. Practice guidelines for blood component therapy: a report by the American Society of Anesthesiologists Task Force on Blood Component Therapy. Anesthesiology 1996; 84:732-747
9. American College of Physicians. Practice strategies for elective red blood cell transfusion. Ann Intern Med 1992; 116: 403-406
10. Weiskopf RB, Viele MK, Feiner J, et al. Human cardiovascular and metabolic response to acute, severe isovolemic anemia. JAMA 1998; 279:217-221
11. Hebert PC, Wells G, Martin C, et al. A Canadian survey of transfusion practices in critically ill patients: Transfusion Requirements in Critical Care Investigators and the Canadian Critical Care Trials Group. Crit Care Med 1998; 26:482-487
12. Rao MP, Boralessa H, Morgan C, et al. Blood component use in critically ill patients. Anaesthesia 2002; 57:530-534
13. Hebert PC, Wells G, Blajchman MA, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care: Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 1999; 11;340:409-417
14. Hebert PC, Blajchman MA, Cook DJ, et al. Do blood transfusions improve outcomes related to mechanical ventilation? Chest 2001; 119:1850-1857
15. Kristiansson M, Soop M, Saraste L, et al. Cytokines in stored red blood cell concentrates: promoters of systemic inflammation and simulators of acute transfusion reactions? Acta Anaesthesiol Scand 1996; 40:496-501
16. Vamvakas EC, Blajchman MA. Deleterious clinical effects of transfusion-associated immunomodulation: fact or fiction? Blood. 2001 1; 97:1180-1195
17. Taylor RW, Manganaro L, O'Brien J, et al. Impact of allogenic packed red blood cell transfusion on nosocomial infection rates in die critically ill patient. Grit Care Med 2002; 30:2249-2254
18. Shorr AF, Dull MS, Kelly KM, et al. Red blood cell transfusion and ventilator-associated pneumonia: a potential link? Crit Care Med 2004 Mar; 32:666-674
19. Roberts GH. Transfusion-related acute lung injury (TRALI). Clin Lab Sci 2004; 17:133-135
20. Looney MR, Cropper MA, Matthay MA. Transfusion-related acute lung injury: a review. Chest 2004; 126:249-258
21. Cohn SM. Blood substitutes in surgery. Surgery 2000; 127: 599-602
22. Corwin HL, Gettinger A, Pearl RG, et al. Efficacy of recombinant human erythropoietin in critically ill patients: a randomized controlled trial. JAMA 2002; 288:2827-2835